Search Results for “EU” – Page 386 – media

FDA approves new treatment for adults with mantle cell lymphoma

The U.S. Food and Drug(FDA) Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy.
- Source: Prnewswire
- 785
- November 1, 2017
Calquence FDA mantle cell lymphoma New Approvals
New Use of A.I. Accurately Detected Cancer 86 Percent of the Time

The quest to better detect cancer has made a potentially huge strides. A study out of Yokohama, Japan, has potentially harnessed artificial intelligence to help detect colorectal cancer even before benign tumors become malignant.
- Source: inverse
- 723
- November 1, 2017
Artificial Intelligence colorectal cancer Market Views
$3.5 Billion Has Been Invested In Digital Health So Far In 2017. Here’s Where The Industry Is Going

Investors in digital health have been busy this year. In the first half of 2017, 188 startups took in $3.5 billion in investments—a record setting amount. It’s not hard to see why. Patients and providers are both looking to digital health tools to get better treatment and improve the relationship dynamic. With all that money flowing into some very intriguing startups, and it’s a good idea to know what the digital health industry holds for us in the coming years.
- Source: huffingtonpost
- 606
- November 1, 2017
digital health doctor Market Views Patients treatment
Samsung Biologics reinforces biologic manufacturing and development partnership with MSD

Samsung Biologics has announced it has expanded its strategic alliance with MSD, or Merck as it is known in the US and Canada, with the signing of a memorandum of understanding. The relationship has come into force to streamline process development and clinical material production for small biotech start-ups focusing on novel drugs.
- Source: pharmafile
- 426
- November 1, 2017
Merck Samsung Biologics
Novartis Slams Down $3.9B for This French Cancer Biotech

Fresh off the heels of its CAR-T approval, Novartis expanded its oncological arsenal with a $3.9 billion acquisition of French cancer firm Advanced Accelerator Applications.
- Source: Biospace
- 802
- October 31, 2017
CAR–T GEP-NETs Market Views neuroendocrine tumors
Ddu Attended CPhI Worldwide in Germany, Gaining Attention from the Whole Industry

The International Pharmaceutical Networking Exhibition (CPhI Worldwide 2017), was held at Ludwig-Erhard-Anlage 1 in Messe, Frankfurt, Germany from the 24th to the 26th of October 2017. As the leading global pharmaceutical & medical device B2B online platform, Ddu attended the exhibition, gaining attention from the whole industry.
- Source: Ddu
- 1,597
- October 31, 2017
CPhI Worldwide 2017 Exhibitions & Activities
FDA Calls BioMarin’s Hemophilia A Drug a Breakthrough

BioMarin Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) granted its valoctocogene roxaparvovec for Hemophilia A Breakthrough Therapy Designation.
- Source: biospace
- 806
- October 31, 2017
Clinical Trial FDA hemophilia A
CDC backs GSK’s Shingrix over Merck & Co’s Zostavax

Prospects for GlaxoSmithKline’s new shingle vaccine Shingrix have been raised after US advisors recommended that it should be used instead of rival Zostavax from Merck & Co.
- Source: Pmlive
- 923
- October 30, 2017
Company Insight HIV Shingrix Tivicay Triumeq vaccine
Pfizer to launch consumer health sale in November

Pfizer plans to kick off an auction process for its consumer healthcare business in November, paving the way for a potential $15 billion-plus sale of the headache pill to lip balm business, sources close to the matter told Reuters.
- Source: Pharmacodia
- 624
- October 30, 2017
Consumer Healthcare Market Views pill
Oral Drug Beats Interferon in First Pediatric MS Trial

In the first randomized controlled trial in pediatric multiple sclerosis, fingolimod (Gilenya) significantly cut relapses compared with interferon beta-1a (Avonex), researchers reported here.
- Source: medpagetoday
- 649
- October 30, 2017
beta-1a Clinical Trials interferon multiple sclerosis pediatric

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.